About Us

Mission statement

Wintermute Biomedical is a US biopharmaceutical startup whose sole focus is to develop next-generation antibiotics in order to address the impending threat of antimicrobial resistance (AMR). Wintermute has developed a truly novel antibiotic compound, which will soon be entering clinical trials. Our vision is to make this antibiotic a reality for the millions of people that fall victim to AMR each year.

Our team

Dr Geoff Rogers

Dr Geoff Rogers – Acting CEO

Geoff is an engineer, entrepreneur and company executive, with extensive experience in the healthcare sector. He has successfully co-founded and led a number of high-growth, high-tech companies.

Dr Thomas Rau

Dr Thomas Rau – Co-Founder & CSO

Tom is a Wintermute co-founder and inventor, with over 20 years experience in scientific research. He specializes in neuroscience and medical microbiology, with a particular focus on multidrug-resistant bacteria.

Weston Hale

Weston Hale – Co-Founder & Director of R&D

Wes is a Wintermute co-founder and inventor, with over 7 years experience in scientific research. He specializes in microbiology and molecular biology, and leads the development of Wintermute’s next-generation antibiotic.